Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs Immunovant, Inc. (IMVT)

Belite Bio, Inc. Sponsored ADR and Immunovant, Inc. are both Biotechnology companies. Belite Bio, Inc. Sponsored ADR and Immunovant, Inc. are of similar size ($6.2B and $5.7B). Across the 9 metrics below, Belite Bio, Inc. Sponsored ADR leads on 6 and Immunovant, Inc. on 3.

Valuation

Metric BLTE IMVT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 7.45 7.47 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (1.91%) (10.55%) (33.15%)
Free cash flow yield (1.16%) (7.55%) (25.50%)

Profitability

Metric BLTE IMVT Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (80.10%) (56.36%)
Return on assets (21.60%) (71.10%) (48.04%)
Return on invested capital (9.55%) 0.00% 0.00%

Growth

Metric BLTE IMVT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (95.76%) (1.47%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE IMVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.56 7.27 4.72
Net debt to EBITDA 5.88 1.69 0.96

Dividend

Metric BLTE IMVT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLTE IMVT Biotechnology median
Market cap 6.15b 5.68b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack